文献速递肝病

生物打印人化学诱导多能干细胞来源的功能性肝细胞类器官治疗肝衰竭

Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure.
PubMed 文献 · Gut · 2025-06-06

本研究以人化学诱导多能干细胞(hCiPSCs)为来源,在透氧微孔装置中制备高活力功能性肝细胞类器官(hCiPSC-HOs),并采用基于球体的生物打印构建肝组织模型(3DP-HOs)。3DP-HOs在体外保持肝脏特异性功能,腹腔植入可显著改善CCl4诱导的慢加急性肝衰竭小鼠及Fah-/-肝衰竭小鼠的生存,并减轻肝损伤、炎症和纤维化,促进肝再生。

要点

  • hCiPSCs为无基因组整合的细胞来源,可制备高活力功能性肝细胞类器官。
  • 基于球体的生物打印肝组织模型(3DP-HOs)体外维持肝脏特异性功能。
  • 3DP-HOs腹腔植入显著改善两种肝衰竭小鼠模型的生存与肝脏指标。

核心结论

  • 生物打印肝组织模型对肝衰竭表现出显著的治疗效果,在肝脏再生医学临床研究中具有很大潜力。

研究设计与样本

  • 研究以人化学诱导多能干细胞(hCiPSCs)为细胞来源制备功能性肝细胞类器官(hCiPSC-HOs),并使用透氧微孔装置增强氧气供应。
  • 采用基于球体的生物打印构建肝组织模型(3DP-HOs),并将其腹腔植入肝衰竭小鼠。

主要发现

  • 与基于单细胞生物打印构建的模型相比,3DP-HOs表现出更高的细胞活力。
  • 3DP-HOs的基因表达谱与hCiPSC-HOs高度相似,并维持肝脏特异性功能。
  • 3DP-HOs植入显著改善CCl4诱导的慢加急性肝衰竭小鼠的生存。
  • 3DP-HOs植入也显著改善Fah-/-肝衰竭小鼠的生存。
  • 3DP-HOs显著降低肝损伤、炎症和纤维化指标,同时促进肝再生和生物功能表达。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To treat liver failure, three-dimensional (3D) bioprinting is a promising technology used to construct hepatic tissue models. However, current research on bioprinting of hepatic tissue models primarily relies on conventional single-cell-based bioprinting, where individual functional hepatocytes are dispersed and isolated within hydrogels, leading to insufficient treatment outcomes due to inadequate cell functionality. OBJECTIVE: Here, we aim to bioprint a hepatic tissue model using functional hepatocyte organoids (HOs) and evaluate its liver-specific functions in vitro and in vivo. DESIGN: Human chemically induced pluripotent stem cells (hCiPSCs) were used as a robust and non-genome-integrative cell source to produce highly viable and functional HOs (hCiPSC-HOs). An oxygen-permeable microwell device was used to enhance oxygen supply, ensuring high cell viability and promoting hCiPSC-HOs maturation. To maintain the long-term biofunction of hCiPSC-HOs, spheroid-based bioprinting was employed to construct hepatic tissue models (3DP-HOs). 3DP-HOs were intraperitoneally implanted in mice with liver failure. RESULTS: 3DP-HOs demonstrated enhanced cell viability when compared with a model fabricated using single-cell-based bioprinting and exhibited gene profiles closely resembling hCiPSC-HOs while maintaining liver-specific functionality. Moreover, 3DP-HOs implantation significantly improved survival in mice with CCl4-induced acute-on-chronic liver failure and also Fah-/- mice with liver failure. 3DP-HOs significantly reduced liver injury, inflammation and fibrosis indices while promoting liver regeneration and biofunction expression. CONCLUSION: Our bioprinted hepatic tissue model exhibits remarkable therapeutic efficacy for liver failure and holds great potential for clinical research in the field of liver regenerative medicine.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Li G, He J, Shi J, et al. Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure. Gut. 2025. PMID: 40032498. doi:10.1136/gutjnl-2024-333885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。